Ontology of Cardiovascular Drug Adverse Events
Created in 2016
How to cite this record FAIRsharing.org: OCVDAE; Ontology of Cardiovascular Drug Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.a557he; Last edited: Jan. 8, 2019, 1:38 p.m.; Last accessed: Aug 14 2020 12:49 a.m.
Record added: Oct. 24, 2017, 9:41 a.m.
Record updated: Feb. 19, 2018, 7:43 p.m. by The FAIRsharing Team.
Edits to 'https://fairsharing.org/FAIRsharing.a557he' by 'The FAIRsharing Team' at 19:43, 19 Feb 2018 (approved): 'description' has been modified: Before: OCVDAE is a biomedical ontology of cardiovascular disease drug-associated adverse events After: With increased usage of cardiovascular drugs (CVDs) for treating cardiovascular diseases, it is important to analyze CVD-associated adverse events (AEs). The Ontology of Cardiovascular Drug Adverse Events (OCVDAE) is an ontology of adverse events associated with cardiovascular disease drugs. It extends the Ontology of Adverse Events (OAE) and NDF-RT. OCVDAE includes 194 CVDs, CVD ingredients, mechanisms of actions (MoAs), and CVD-associated 736 AEs.
|support email||Yongqun Oliver He|
|online documentation||GitHub Repository|
No XSD schemas defined
Conditions of Use
View in BioPortal.
No guidelines defined
Models and Formats
No syntax standards defined
No identifier schema standards defined
No metrics standards defined
No Related Databases
This record is not implemented by any policy.
This record is in need of a maintainer. If you login, you'll be able to claim this record.